High prevalence of extended-spectrum β-lactamase-producing strains among blood isolates of Enterobacter spp. collected in a tertiary hospital during an 8-year period and their antimicrobial susceptibility patterns

被引:32
作者
Pai, HJ
Hong, JY
Byeon, JH
Kim, YK
Lee, HJ
机构
[1] Hanyang Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul 133791, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea
关键词
D O I
10.1128/AAC.48.8.3159-3161.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Of 72 blood isolates of Enterobacter spp. collected over an 8-year period, 50% (36 of 72) were derepressed or partially derepressed AmpC mutants. The extended-spectrum beta-lactamase (ESBL) production rate was 43% (31 of 7 isolates), and 67.3% (31 of 46) of extended-spectrum cephalosporin-resistant strains produced ESBLs. Thus, a confirmatory test for ESBL production is necessary for extended-spectrum cephalosporin-resistant Enterobacter spp.
引用
收藏
页码:3159 / 3161
页数:3
相关论文
共 19 条
[1]   Epidemiology of extended-spectrum β-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period [J].
Cantón, R ;
Oliver, A ;
Coque, TM ;
Varela, MD ;
Pérez-Díaz, JC ;
Baquero, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (04) :1237-1243
[2]   BACTERIAL-CELL WALL RECYCLING PROVIDES CYTOSOLIC MUROPEPTIDES AS EFFECTORS FOR BETA-LACTAMASE INDUCTION [J].
JACOBS, C ;
HUANG, LJ ;
BARTOWSKY, E ;
NORMARK, S ;
PARK, JT .
EMBO JOURNAL, 1994, 13 (19) :4684-4694
[3]   Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli [J].
Jacoby, GA ;
Han, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (04) :908-911
[4]  
Jorgenson J. H., 1999, MANUAL CLIN MICROBIO, P1526
[5]   Rapid discriminatory detection of genes coding for SHV β-lactamases by ligase chain reaction [J].
Kim, J ;
Lee, HJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) :1860-1864
[6]   Bloodstream infections by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children:: Epidemiology and clinical outcome [J].
Kim, YK ;
Pai, H ;
Lee, HJ ;
Park, SE ;
Choi, EH ;
Kim, J ;
Kim, JH ;
Kim, EC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) :1481-1491
[7]   BETA-LACTAMASES IN LABORATORY AND CLINICAL RESISTANCE [J].
LIVERMORE, DM .
CLINICAL MICROBIOLOGY REVIEWS, 1995, 8 (04) :557-&
[8]   Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent β-lactamases [J].
Livermore, DM ;
Oakton, KJ ;
Carter, MW ;
Warner, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (10) :2831-2837
[9]   Detection of β-lactamase-mediated resistance [J].
Livermore, DM ;
Brown, DFJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 :59-64
[10]   USE OF ANALYTICAL ISOELECTRIC FOCUSING FOR DETECTION AND IDENTIFICATION OF BETA-LACTAMASES [J].
MATTHEW, M ;
HARRIS, AM ;
MARSHALL, MJ ;
ROSS, GW .
JOURNAL OF GENERAL MICROBIOLOGY, 1975, 88 (MAY) :169-178